New Zealand Business Daily
SEE OTHER BRANDS

Keeping up with business and economy news from New Zealand

Proteomics International Laboratories Ltd (PIQ.AX) Appointment of Company Secretary

Perth, Oct 7, 2025 AEST (ABN Newswire) - Proteomics International Laboratories Ltd (googlechartASX:PIQ) (googlechartPIQLF:OTCMKTS), a pioneer in precision diagnostics, is pleased to announce the appointment of David Wood as Joint Company Secretary for Proteomics International, effective today. Mr Wood will serve alongside Timothy Luscombe as Joint Company Secretary.

Mr Wood is an Assistant Company Secretary at Bio101 Financial Advisory (Bio101), a financial services firm providing outsourced CFO, taxation, and company secretarial solutions to the Healthcare sector. He has over 15 years of legal and governance experience working with public and private companies in Australia and currently serves as Company Secretary for several ASX-listed, public unlisted, and private Healthcare companies. Mr Wood holds a Bachelor of Business from RMIT University and a Certificate in Governance Practice from the Governance Institute of Australia.

About Proteomics International Laboratories Ltd

Proteomics International Laboratories LtdProteomics International Laboratories (ASX:PIQ) is a wholly owned subsidiary and trading name of PILL, a medical technology company at the forefront of predictive diagnostics and bioanalytical services. The Company specialises in the area of proteomics - the industrial scale study of the structure and function of proteins. Proteomics International's mission is to improve the quality of lives by the creation and application of innovative tools that enable the improved treatment of disease.

abnnewswire.com 



Related Companies

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions